PCSK9

Clinical trials for PCSK9 explained in plain language.

Never miss a new study

Get alerted when new PCSK9 trials appear

Sign up with your email to follow new studies for PCSK9, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to stop heart attacks before they happen

Disease control Recruiting now

This study is testing whether adding a newer type of cholesterol-lowering drug (called a PCSK9 inhibitor) to standard treatment can better prevent heart attacks, strokes, and related deaths. It will involve about 3,600 adults who have high-risk, unstable plaque buildup in their h…

Matched conditions: PCSK9

Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

PCSK9

Get alerted when new PCSK9 trials appear

New drug combo aims to stop heart attacks before they happen